DOI: 10.1002/ccr3.8758 ISSN: 2050-0904
Can lithium be used in the setting of clozapine commencement in patients with COVID ‐19 associated neutropenia: A case report
Jin Quan Eugene Tan, Jessica L. Dawson, Tarun Bastiampillai - General Medicine
Key Clinical Message
COVID‐19 infection may increase the likelihood of neutropenia in patients already on clozapine. In clozapine treated patients experiencing COVID‐19 associated neutropenia, adjunct therapy with lithium can be considered.